Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD).

Mariabeatrice PrincipiFabio Salvatore MacalusoAlessia TodeschiniFederica FacciottiAntonella ContaldoFabiana CastiglioneOlga Maria NardoneRocco SpagnuoloPatrizia DoldoGaia RiguccioFrancesco Simone ConfortiChiara ViganòMarta AscolaniGionata FiorinoCarmen CorrealeGiorgia BodiniMonica MillaGiulia ScardinoMarta VerneroFederico DesideriFlavio CaprioliMariella ManninoGiuseppe RizzoAmbrogio Orlandonull null

Published in: European journal of gastroenterology & hepatology (2023)

The vaccine reactions experienced in IBD patients were mostly self-limited. We found high acceptance and good safety of SARS-CoV-2 vaccination in our cohort.

Keyphrases

sars cov
coronavirus disease
patients with inflammatory bowel disease
end stage renal disease
respiratory syndrome coronavirus
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
risk factors